Suita, Japan

Hiroshi Funakoshi



Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Suita, JP (2013)
  • Hokkaido, JP (2013)

Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiroshi Funakoshi: Innovator in Medical Therapeutics

Introduction

Hiroshi Funakoshi is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of medical therapeutics, particularly in the treatment of diseases related to polyglutamine aggregation and spinal cord injuries. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Hiroshi Funakoshi's latest patents include an agent for treating polyglutamine aggregation-caused diseases and a therapeutic agent for spinal cord injuries. The first patent discloses an agent that comprises, as an active ingredient, either HGF protein or a partial peptide of HGF protein that is substantially equivalent in activity to HGF protein. The second patent focuses on a therapeutic agent effective for the fundamental treatment of spinal cord injuries and demyelinating diseases, which also utilizes HGF protein as an active ingredient.

Career Highlights

Throughout his career, Hiroshi Funakoshi has worked with esteemed institutions such as Osaka University and Kringle Pharma Inc. His research has been pivotal in advancing therapeutic options for challenging medical conditions.

Collaborations

Hiroshi has collaborated with notable colleagues, including Toshikazu Nakamura and Daisuke Miyazawa. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Hiroshi Funakoshi's work exemplifies the spirit of innovation in medical science. His patents and collaborations highlight his commitment to improving therapeutic options for patients suffering from serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…